Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Background/Aims: The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis plus defined markers of metabolic dysfunction, irres...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Revisão |
| 語言: | 英语 |
| 出版: |
2024
|
| 在線閱讀: | https://doi.org/10.3350/cmh.2024.0109 https://www.e-cmh.org/upload/pdf/cmh-2024-0109.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|